Philippe Saïag

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

Michael A. Davies, Philippe Saïag, Caroline Robert et al. · The Lancet Oncology · 2017 · 759 citations · Full text

Medicine, Melanoma, Pathology +5

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

Claus Garbe, Ketty Peris, Axel Hauschild et al. · European Journal of Cancer · 2016 · 569 citations

Skin Cancer, Medicine, Melanoma +6

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study

Marie‐Françoise Avril, Steinar Aamdal, Jean‐Jacques Grob et al. · Journal of Clinical Oncology · 2004 · 470 citations

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – <scp>EDF</scp> in cooperation with <scp>EADV</scp> and <scp>IPC</scp>

Alexander Nast, Paolo Gisondi, Anthony D. Ormerod et al. · Journal of the European Academy of Dermatology and Venereology · 2015 · 388 citations · Full text

Please Note, Journal Citation Report, Autoimmune Disease +15

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 364 citations · Full text

Surgical Oncology, Medicine, Melanoma +8